- Home
- GDYN vs NEO Comparison
GDYN vs NEO Comparison
Compare GDYN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- NEO
- Stock Information
- Founded
- GDYN 2006
- NEO 2001
- Country
- GDYN United States
- NEO United States
- Employees
- GDYN N/A
- NEO N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- NEO Precision Instruments
- Sector
- GDYN Technology
- NEO Health Care
- Exchange
- GDYN Nasdaq
- NEO Nasdaq
- Market Cap
- GDYN 1.6B
- NEO 1.2B
- IPO Year
- GDYN N/A
- NEO 1999
- Fundamental
- Price
- GDYN $16.36
- NEO $9.52
- Analyst Decision
- GDYN Strong Buy
- NEO Strong Buy
- Analyst Count
- GDYN 6
- NEO 10
- Target Price
- GDYN $19.17
- NEO $19.78
- AVG Volume (30 Days)
- GDYN 884.2K
- NEO 1.6M
- Earning Date
- GDYN 05-01-2025
- NEO 04-29-2025
- Dividend Yield
- GDYN N/A
- NEO N/A
- EPS Growth
- GDYN N/A
- NEO N/A
- EPS
- GDYN 0.05
- NEO N/A
- Revenue
- GDYN $350,571,000.00
- NEO $660,566,000.00
- Revenue This Year
- GDYN $24.35
- NEO $12.89
- Revenue Next Year
- GDYN $17.42
- NEO $11.36
- P/E Ratio
- GDYN $327.50
- NEO N/A
- Revenue Growth
- GDYN 12.04
- NEO 11.65
- 52 Week Low
- GDYN $9.07
- NEO $8.98
- 52 Week High
- GDYN $25.50
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- GDYN 29.17
- NEO 37.87
- Support Level
- GDYN $16.57
- NEO $9.00
- Resistance Level
- GDYN $17.91
- NEO $10.95
- Average True Range (ATR)
- GDYN 1.07
- NEO 0.83
- MACD
- GDYN -0.34
- NEO 0.08
- Stochastic Oscillator
- GDYN 3.95
- NEO 21.43
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.